Patterns of antibody binding to aquaporin-4 isoforms in neuromyelitis optica.
about
Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patientsAquaporin 4 and neuromyelitis opticaAntibodies as Mediators of Brain Pathology[Ultrahigh field MRI in context of neurological diseases].Neuromyelitis optica: clinical features, immunopathogenesis and treatment.Large-Scale in-House Cell-Based Assay for Evaluating the Serostatus in Patients with Neuromyelitis Optica Spectrum Disorder Based on New Diagnostic Criteria.Heterogeneous pattern of retinal nerve fiber layer in multiple sclerosis. High resolution optical coherence tomography: potential and limitationsFrequency of autoantibodies and connective tissue diseases in Chinese patients with optic neuritis.Aquaporin-4: orthogonal array assembly, CNS functions, and role in neuromyelitis optica.High resolution spectral domain optical coherence tomography (SD-OCT) in multiple sclerosis: the first follow up study over two years.Aquaporin-4 antibody testing: direct comparison of M1-AQP4-DNA-transfected cells with leaky scanning versus M23-AQP4-DNA-transfected cells as antigenic substrate.Small-molecule inhibitors of NMO-IgG binding to aquaporin-4 reduce astrocyte cytotoxicity in neuromyelitis optica.Systemic inflammation and the brain: novel roles of genetic, molecular, and environmental cues as drivers of neurodegeneration.Binding affinity and specificity of neuromyelitis optica autoantibodies to aquaporin-4 M1/M23 isoforms and orthogonal arraysAn optimized immunohistochemistry technique improves NMO-IgG detection: study comparison with cell-based assaysNeuromyelitis optica in Austria in 2011: to bridge the gap between neuroepidemiological research and practice in a study population of 8.4 million people.Aquaporin-4 autoantibodies in Neuromyelitis Optica: AQP4 isoform-dependent sensitivity and specificityUpdate on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS).Model of aquaporin-4 supramolecular assembly in orthogonal arrays based on heterotetrameric association of M1-M23 isoforms.Reduction in serum aquaporin-4 antibody titers during development of a tumor-like brain lesion in a patient with neuromyelitis optica: a serum antibody-consuming effect?Brain-reactive antibodies and disease.New insights into neuromyelitis opticaComplement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disordersAquaporin-4 antibody isoform binding specificities do not explain clinical variations in NMODevelopment of an Aquaporin-4 Orthogonal Array of Particle-Based ELISA for Neuromyelitis Optica Autoantibodies Detection.Anti-aquaporin-4 monoclonal antibody blocker therapy for neuromyelitis optica.Aquaporins in clinical medicine.Aquaporin-4 Mz isoform: brain expression, supramolecular assembly and neuromyelitis optica antibody binding.Selective Impairment of Spatial Cognition Caused by Autoantibodies to the N-Methyl-D-Aspartate Receptor.Antibodies to aquaporin-1 are not present in neuromyelitis optica.Astrocytic autoantibody of neuromyelitis optica (NMO-IgG) binds to aquaporin-4 extracellular loops, monomers, tetramers and high order arraysOrthogonal array formation by human aquaporin-4: examination of neuromyelitis optica-associated aquaporin-4 polymorphisms.Epigallocatechin-3-gallate: a useful, effective and safe clinical approach for targeted prevention and individualised treatment of neurological diseases?Aquaporin 4 molecular mimicry and implications for neuromyelitis optica.Characterization of the binding pattern of human aquaporin-4 autoantibodies in patients with neuromyelitis optica spectrum disordersMOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.Evaluation of aquaporin-4 antibody assays.Finding NMO: The Evolving Diagnostic Criteria of Neuromyelitis Optica.Aquaporin-4 antibodies (NMO-IgG) as a serological marker of neuromyelitis optica: a critical review of the literature.What's new in neuromyelitis optica? A short review for the clinical neurologist.
P2860
Q21093230-48BF2C08-2133-453D-9821-F9BB31B0734DQ24613666-746479B5-6902-48BF-B59B-098BAFB7FE7FQ26780374-0A64BAE9-FDD6-4BE4-90A9-A1DBA0BFC2C2Q30759627-D172AB1E-B101-4F28-93AA-4BF80F56DC9EQ30785267-DB668484-AAE6-4391-B63C-154C98EFC42CQ33567268-373EE69B-AE8D-4913-8E81-67CA211F8E2DQ33747645-B072EE8E-BDA7-42BE-AE5B-83ED756C7B9EQ33783819-CF2B54F2-46A4-474C-8002-D05B757C21F0Q33892339-9DFE4A3F-6175-49BA-B6D3-1E2279A4AA3FQ33911364-7E2DA22A-6473-406A-95F6-1209768AE574Q34026880-42360819-9B08-4298-BD08-6A6C6DDE8650Q34154265-0421C929-18E8-415E-8A23-E6AA4A00BBA5Q34463760-7D80944E-9A84-4F47-AB33-3608A0D20C48Q34963829-80167F50-7A98-4014-9451-6AE7DB04B374Q35041142-A5AB5643-6E9A-416E-B40C-CCD34981C081Q35041447-0DFC9938-4B6A-4F1C-9B3E-52E530519670Q35048235-BFDA63F7-B2BE-4CB0-8A45-EC4E15F321F3Q35052199-32E3E44C-0471-4DE8-844D-256C3FE591D5Q35070474-8BB4D3C5-FBA4-4BFF-A855-E31C61C1F0D3Q35081997-BFE44059-BC42-4A81-96DC-A922F4EFD636Q35458567-71771205-9EC5-4CDF-8A3C-73292EDA367CQ35539641-78599026-26BD-4B05-9865-74B22B741A51Q35753620-3E2DB966-0425-4C6F-8B08-30B922D45FD2Q35764733-8B941589-B5B4-4AE0-8388-7BBCB2143700Q35850484-71E78456-263A-43FE-849C-AF1A7C7DDE16Q35857869-C73FDB78-4010-4FB7-8AA1-03FF8680B690Q35870411-E45268D1-7F33-45D5-8779-5999CB218405Q35892159-20985C80-752B-4A88-8139-B015D2775F5EQ35947538-F3A769D9-E6F2-4E73-9BB1-46B91E24B1F7Q36118318-81FD6E7F-50B2-45A1-839C-90752EC2A67AQ36431376-65538D74-3CD0-4289-A266-1DDB243F29C2Q36638942-63E5A100-8E5C-4DD8-B7CE-5687C8D72E36Q36648907-D43ABD7D-4519-4FFC-9BCE-96112D934E5CQ36929281-7AC56571-B3E9-466F-80A3-6489BA0EC796Q37059594-0132A637-AB4B-4B91-A63C-5512E88392ACQ37374434-7F718AC1-7B7F-4451-83A5-CDD376AA0AFCQ37404328-5BE242DA-BD6F-44DE-B6FC-4D05023824C1Q37470003-C2B48413-A119-46FF-AF59-481276EA3E6DQ38151920-B896A777-1E92-49AA-9204-166FFDAC30F2Q39176987-BCB7E4B9-475F-4ACF-A4F2-B33C69889750
P2860
Patterns of antibody binding to aquaporin-4 isoforms in neuromyelitis optica.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Patterns of antibody binding to aquaporin-4 isoforms in neuromyelitis optica.
@ast
Patterns of antibody binding to aquaporin-4 isoforms in neuromyelitis optica.
@en
Patterns of antibody binding to aquaporin-4 isoforms in neuromyelitis optica.
@nl
type
label
Patterns of antibody binding to aquaporin-4 isoforms in neuromyelitis optica.
@ast
Patterns of antibody binding to aquaporin-4 isoforms in neuromyelitis optica.
@en
Patterns of antibody binding to aquaporin-4 isoforms in neuromyelitis optica.
@nl
prefLabel
Patterns of antibody binding to aquaporin-4 isoforms in neuromyelitis optica.
@ast
Patterns of antibody binding to aquaporin-4 isoforms in neuromyelitis optica.
@en
Patterns of antibody binding to aquaporin-4 isoforms in neuromyelitis optica.
@nl
P2093
P2860
P50
P1433
P1476
Patterns of antibody binding to aquaporin-4 isoforms in neuromyelitis optica.
@en
P2093
Andreas Lutterotti
Bettina Kuenz
Fahmy Aboul-Enein
Franziska Di Pauli
Kathrin Schanda
Maria K Storch
Sven Jarius
Thomas Berger
Wolfgang Kristoferitsch
P2860
P304
P356
10.1371/JOURNAL.PONE.0010455
P407
P577
2010-05-05T00:00:00Z